Table 1.
Baseline Characteristics upon ILD Program Evaluation
| Variable | UCD Cohort (n = 102) | UChicago Cohort (n = 44) |
|---|---|---|
| Age, mean (SD) | 72.5 (9.5) | 59.8 (14.1) |
| Male, n (%) | 64 (62.8) | 17 (38.6) |
| Race, n (%) | ||
| White | 87 (85.3) | 9 (20.5) |
| African American | 3 (2.9) | 34 (77.3) |
| Hispanic | 5 (4.9) | 1 (2.3) |
| Asian | 7 (6.9) | 0 (0) |
| Smoking History | ||
| Never, n (%) | 38 (37.3) | 17 (38.6) |
| Former or current, n (%) | 64 (62.8) | 27 (61.4) |
| Pack-years if former/current, median (IQR) | 20 (10–42.5) | 22 (15–40) |
| Pulmonary Referral Reason | ||
| Abnormal imaging/ILD, n (%) | 63 (61.8) | 35 (79.6) |
| Cough and/or dyspnea, n (%) | 19 (18.6) | 7 (15.9) |
| Abnormal PFT | 6 (5.9) | 1 (2.3) |
| Other, n (%) | 14 (13.7) | 1 (2.3) |
| ILD Diagnosis, n (%) | ||
| Idiopathic pulmonary fibrosis | 28 (27.5) | 12 (27.3) |
| CTD-associated ILD | 20 (19.6) | 22 (50) |
| Chronic HP | 10 (9.8) | 2 (18.2) |
| Unclassifiable Fibrosis | 34 (33.3) | 8 (18.2) |
| Other ILD | 10 (9.8) | 0 (0) |
| Pulmonary Function | ||
| Total lung capacity (% predicted), mean (SD) | 79 (17) | 72 (18) |
| Forced vital capacity (% predicted), mean (SD) | 83 (19) | 66 (18) |
| Diffusion capacity (% predicted), mean (SD) | 59 (17) | 54 (20) |